Skip to main content
Year archive

Ambalal Sarabhai Enterprise Ltd. — 2021 filings

All 44 regulatory filings released by Ambalal Sarabhai Enterprise Ltd. (AMBALALSA) in 2021, sourced directly from the official regulator.

44 Filings
2021 Period
2021 filings (44)
Filing Released Lang
This is to inform you that pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading ....
Regulatory Filings
2021-12-31 English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), ....
Regulatory Filings
2021-11-13 English
Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), ....
Regulatory Filings
2021-11-13 English
AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2021-11-03 English
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, ....
Regulatory Filings
2021-10-14 English
We are hereby enclosing the intimation for Closure of Trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Friday, ....
Regulatory Filings
2021-09-30 English
We are hereby enclosing the intimation for Closure of Trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Friday, ....
Regulatory Filings
2021-09-30 English
With reference to the captioned subject, we are enclosing herewith Declaration of results of remote e-voting and e-voting during the 43rd Annual General Meeting of the Company held on Thursday, ....
Regulatory Filings
2021-09-23 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para A of Part A of Schedule III of the Listing ....
Regulatory Filings
2021-09-23 English
COSARA DIAGNOSTICS receives CDSCO License to manufacture SARAGENE® DENGUE RT-PCR Test Kit.
Regulatory Filings
2021-09-16 English
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Notice convening 43rd Annual General Meeting (''AGM'') along ....
Regulatory Filings
2021-09-01 English
Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the ....
Regulatory Filings
2021-08-11 English
Following matters have been discussed, considered and approved by the Board of Directors in its meeting held on 11th August, 2021: 1. Pursuant to Regulations 30 & 33 of Chapter IV read ....
Regulatory Filings
2021-08-11 English
AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2021-08-05 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2021-07-26 English
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, ....
Regulatory Filings
2021-07-08 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions on a ....
Regulatory Filings
2021-07-03 English
Pursuant to SEBl vide its circular No. CIR/CFD/CMD1/27/2019 dated 08.02.2019, please find enclosed herewith the Annual Secretarial Compliance Report dated 30th June,2021 for the Financial ....
Regulatory Filings
2021-06-30 English
We are hereby enclosing the intimation for Closure of Trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Thursday, ....
Regulatory Filings
2021-06-30 English
We hereby enclosing an announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for settlement of long pending case. You are ....
Regulatory Filings
2021-06-08 English
Declaration On Unmodified Opinion on the Audited Financial Statements for financial year ended March 31, 2021
Regulatory Filings
2021-06-05 English
We are hereby enclosing the Audited Financial Results of the Company for the Quarter & Financial Year ended on 31/03/2021
Regulatory Filings
2021-06-04 English
We wish to inform you that following matters have been discussed, considered and approved by the Board of Directors in its meeting held on 4th June, 2021: 1. The Board has considered, ....
Regulatory Filings
2021-06-04 English
AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2021 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2021-05-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Caplin Viniyog Pvt Ltd
Regulatory Filings
2021-05-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Caplin Viniyog Pvt Ltd
Regulatory Filings
2021-05-20 English
Synbiotics Limited, a subsidiary of ASE is the only manufacturer of the Active Pharmaceutical Ingredient (API) Amphotericin B in India and looking at the current outbreak of MUCORMYCOSIS ....
Regulatory Filings
2021-05-11 English
CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited, recognized for Work Combating COVID-19 Surge in India. The detailed ....
Regulatory Filings
2021-05-03 English
Pursuant to the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by Large Entities, we wish to state that for ....
Regulatory Filings
2021-04-30 English
With reference to the appended subject and email dated April 26, 2021, it is to inform you that the movement in price is due to the market demand and supply and there is no other price ....
Regulatory Filings
2021-04-26 English
We herewith submit Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the half year ended on 31st March,2021 which is given ....
Regulatory Filings
2021-04-21 English
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, We enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, ....
Regulatory Filings
2021-04-20 English
Certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations") for the half year ended ....
Regulatory Filings
2021-04-20 English
We are hereby enclosing the intimation for Closure of Trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Thursday, ....
Regulatory Filings
2021-03-30 English
CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited has received CDSCO License to manufacture SARAGENE® Chikungunya Virus (CHIKV) Test Kit. ....
Regulatory Filings
2021-03-22 English
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company has entered into a Share Purchase Agreement ....
Regulatory Filings
2021-03-22 English
In continuation to our corporate disclosure dated 26th November,2020 and 02nd January, 2021, which were filed with exchange in due course and in line with the corporate disclosure requirement ....
Regulatory Filings
2021-03-05 English
Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the ....
Regulatory Filings
2021-02-12 English
Following matters have been discussed, considered and approved by the Board of Directors in its meeting held on 12th February, 2021: 1. Approval of Financial results for the quarter ....
Regulatory Filings
2021-02-12 English
AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve To consider and ....
Regulatory Filings
2021-02-05 English
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, ....
Regulatory Filings
2021-01-15 English
With reference to significant movement in price, we are hereby enclosing the reply to the clarification sought by the stock exchange with reference to the significant movement in the price ....
Regulatory Filings
2021-01-08 English
In continuation to our corporate disclosure dated 26th November,2020 which was filed with exchange on 26th November,2020 and in line with the corporate disclosure requirement under Regulation ....
Regulatory Filings
2021-01-02 English
We are hereby enclosing the intimation for closure of trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from ....
Regulatory Filings
2021-01-01 English